Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avacopan in Moderate to Severe Hidradenitis Suppurativa
NCT03852472Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avacopan in hidradenitis suppurativa (HS), sponsored by Amgen. Started Dec 2018; status: completed.
02
Drugs
avacopan
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT03852472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852472.